You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 28, 2025

List of Excipients in API sitagliptin


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing sitagliptin

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
Merck Sharp & Dohme LLC JANUVIA sitagliptin 0006-0221 ANHYDROUS DIBASIC CALCIUM PHOSPHATE 2027-05-24
Merck Sharp & Dohme LLC JANUVIA sitagliptin 0006-0221 CELLULOSE, MICROCRYSTALLINE 2027-05-24
Merck Sharp & Dohme LLC JANUVIA sitagliptin 0006-0221 CROSCARMELLOSE SODIUM 2027-05-24
Merck Sharp & Dohme LLC JANUVIA sitagliptin 0006-0221 FERRIC OXIDE RED 2027-05-24
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Get Started Free

Detailed excipient profiles for sitagliptin

Excipient focus: ALUMINUM OXIDE

Excipient focus: ANHYDROUS CITRIC ACID

Excipient focus: ANHYDROUS DIBASIC CALCIUM PHOSPHATE

Excipient focus: BUTYLATED HYDROXYANISOLE

Excipient focus: CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS

Excipient focus: CARNAUBA WAX

Excipient focus: CELLULOSE, MICROCRYSTALLINE

Excipient focus: CROSCARMELLOSE SODIUM

Excipient focus: EDETATE DISODIUM

Excipient focus: FD&C BLUE NO. 2

Excipient focus: FD&C YELLOW NO. 6

Excipient focus: FERRIC OXIDE RED

Excipient focus: FERRIC OXIDE YELLOW

Excipient focus: FERROSOFERRIC OXIDE

Excipient focus: HYDROXYETHYL CELLULOSE

Excipient focus: HYDROXYPROPYL CELLULOSE

Excipient focus: HYPROMELLOSE 2208

Excipient focus: HYPROMELLOSE 2910

Excipient focus: INDIGOTINDISULFONATE SODIUM

Excipient focus: KAOLIN

Excipient focus: LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE

sitagliptin drug variants containing LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE

Glossary
Company Ingredient NDC
Zydus Pharmaceuticals (USA) Inc sitagliptin and metformin hydrochloride 70710-1786
Zydus Pharmaceuticals (USA) Inc sitagliptin and metformin hydrochloride 70710-1986
Zydus Lifesciences Limited sitagliptin and metformin hydrochloride 70771-1859
Zydus Lifesciences Limited sitagliptin and metformin hydrochloride 70771-1869
>Company >Ingredient >NDC

Subscribe to access the full database, or Get Started Free

Excipient focus: MAGNESIUM STEARATE

Excipient focus: MALIC ACID

Excipient focus: METHYLPARABEN SODIUM

Excipient focus: POLYETHYLENE GLYCOL

Excipient focus: POLYETHYLENE GLYCOL 3350

Excipient focus: POLYETHYLENE GLYCOLS

Excipient focus: POLYSORBATE 80

Excipient focus: POLYVINYL ALCOHOL

Excipient focus: POVIDONE

Excipient focus: POVIDONE K30

Excipient focus: PROPYL GALLATE

Excipient focus: SILICON DIOXIDE

Excipient focus: SODIUM CITRATE

Excipient focus: SODIUM LAURYL SULFATE

Excipient focus: SODIUM STEARYL FUMARATE

Excipient focus: STARCH, CORN

Excipient focus: TALC

Excipient focus: TITANIUM DIOXIDE

Excipient focus: WATER

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2025 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
 NCE-1 Patent Challenge Dates 2025 - 2026
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links